MAIA Biotechnology, Inc. (MAIA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+24403.2%

$269.53

vs $1.10 price

Levered DCF

$269.59

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

-2.92

Distress zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-2.19×	-1.89×	-0.79×	-2.06×	-3.78×	-7.19×	-7.31×
P/B	20.68×	12.09×	32.49×	3.83×	5.17×	-14.22×	-274.41×
P/S	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	384.39×	-1.48×	-0.42×	-1.37×	-3.14×	0×	0×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	1.66×	2.65×	1.53×	3.61×	4.97×	0.44×	4.63×
Debt / equity	0×	0×	0×	0×	0×	-0.14×	-0.2×
Interest coverage	0×	-297,494.91×	0×	-2,321.83×	-9.41×	-221.12×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-942.7%	-639.8%	-4140.8%	-185.4%	-136.2%	198.9%	3755.9%
Return on invested capital	-627.4%	-268.1%	-767.5%	-184.8%	-84.8%	762.1%	-499.7%
Return on assets	-230.8%	-229.0%	-261.3%	-131.2%	-110.4%	-889.0%	-374.3%
Free cash flow yield	-38.4%	-35.7%	-84.2%	-37.1%	-8.7%	-3.9%	-3.3%
Earnings yield	-45.6%	-52.9%	-127.4%	-48.4%	-26.4%	-14.0%	-13.7%
Enterprise value	-$8.6B	$34.3M	$8.4M	$21.6M	$36.9M	$47.2M	$45.8M
Net debt / EBITDA	386.59×	0.41×	0.36×	0.69×	0.9×	0×	0×
Cash conversion cycle (days)	0	0	0	0	0	0	0